Literature DB >> 4100767

The purification of specific antibody as F(ab')2 by the pepsin digestion of antigen-antibody precipitates, and its application to immunoglobulin and complement antigens.

P J Lachmann.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 4100767     DOI： 10.1016/0019-2791(71)90423-x

Source DB:  PubMed          Journal:  Immunochemistry        ISSN： 0019-2791


× No keyword cloud information.
  20 in total

1.  The immunogloblin nature of nephritic factor (NeF).

Authors:  D M Scott; N Amos; J G Sissons; P J Lachmann; D K Peters
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

2.  Haemolytic assays in agarose plates for components of the classical complement pathway: interference by the alternative pathway.

Authors:  A Martin; P J Lachmann
Journal:  Clin Exp Immunol       Date:  1977-01       Impact factor: 4.330

3.  The alternate pathway of complement activation. The role of C3 and its inactivator (KAF).

Authors:  P A Nicol; P J Lachmann
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

4.  Enumeration of immunoglobulin-bearing lymphocytes in whole peripheral blood.

Authors:  M B Pepys; C Sategna-Guidetti; D D Mirjah; M H Wansbrough-Jones; A C Dash
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

5.  The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes.

Authors:  P J Lachmann; M Macanovic; G D Harkiss; R G Oldroyd; J Habicht
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

6.  Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia.

Authors:  J A Charlesworth; D G Williams; E Sherington; P J Lachmann; D K Peters
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

7.  Mechanisms of activation of the properdin system. Studies on properdin electrophoretic mobility in agarose activation of the alternative pathway.

Authors:  C Adam; D G Williams; D K Peters
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

8.  Complement-mediated inhibition of immune precipitation. I. Role of the classical and alternative pathways.

Authors:  J A Schifferli; P Woo; D K Peters
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

9.  Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.

Authors:  C Bruneau; H Bonin
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

10.  Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man. Reconstitution of normal C8 from the mixture of two abnormal C8 molecules.

Authors:  F Tedesco; P Densen; M A Villa; B H Petersen; G Sirchia
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.